Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory T cells phenotype in different clinical forms of Chagas' disease.
de Araújo FF, Vitelli-Avelar DM, Teixeira-Carvalho A, Antas PR, Assis Silva Gomes J, Sathler-Avelar R, Otávio Costa Rocha M, Elói-Santos SM, Pinho RT, Correa-Oliveira R, Martins-Filho OA. de Araújo FF, et al. PLoS Negl Trop Dis. 2011;5(5):e992. doi: 10.1371/journal.pntd.0000992. Epub 2011 May 31. PLoS Negl Trop Dis. 2011. PMID: 21655351 Free PMC article. Review.
Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern.
Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, de Lana M, Pinto Dias JC, Teixeira-Carvalho A, Elói-Santos SM, Martins-Filho OA. Sathler-Avelar R, et al. Microbes Infect. 2008 Feb;10(2):103-13. doi: 10.1016/j.micinf.2007.10.009. Epub 2007 Oct 22. Microbes Infect. 2008. PMID: 18248755 Free article.
Phenotypic Features of Circulating Leukocytes from Non-human Primates Naturally Infected with Trypanosoma cruzi Resemble the Major Immunological Findings Observed in Human Chagas Disease.
Sathler-Avelar R, Vitelli-Avelar DM, Mattoso-Barbosa AM, Perdigão-de-Oliveira M, Costa RP, Elói-Santos SM, Gomes Mde S, Amaral LR, Teixeira-Carvalho A, Martins-Filho OA, Dick EJ Jr, Hubbard GB, VandeBerg JF, VandeBerg JL. Sathler-Avelar R, et al. PLoS Negl Trop Dis. 2016 Jan 25;10(1):e0004302. doi: 10.1371/journal.pntd.0004302. eCollection 2016 Jan. PLoS Negl Trop Dis. 2016. PMID: 26808481 Free PMC article.
Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
Vitelli-Avelar DM, Sathler-Avelar R, Mattoso-Barbosa AM, Gouin N, Perdigão-de-Oliveira M, Valério-Dos-Reis L, Costa RP, Elói-Santos SM, Gomes MS, Amaral LR, Teixeira-Carvalho A, Martins-Filho OA, Dick EJ Jr, Hubbard GB, VandeBerg JF, VandeBerg JL. Vitelli-Avelar DM, et al. Among authors: sathler avelar r. PLoS Negl Trop Dis. 2017 Feb 22;11(2):e0005233. doi: 10.1371/journal.pntd.0005233. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28225764 Free PMC article.
Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, Lage PS, Elói-Santos SM, Corrêa-Oliveira R, Martins-Filho OA. Vitelli-Avelar DM, et al. Scand J Immunol. 2005 Sep;62(3):297-308. doi: 10.1111/j.1365-3083.2005.01668.x. Scand J Immunol. 2005. PMID: 16179017 Free article.
Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA. Vitelli-Avelar DM, et al. Clin Exp Immunol. 2006 Jul;145(1):81-92. doi: 10.1111/j.1365-2249.2006.03123.x. Clin Exp Immunol. 2006. PMID: 16792677 Free PMC article.
Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA. Sathler-Avelar R, et al. Scand J Immunol. 2006 Nov;64(5):554-63. doi: 10.1111/j.1365-3083.2006.01843.x. Scand J Immunol. 2006. PMID: 17032249 Free article. Clinical Trial.
27 results